Published in Arch Immunol Ther Exp (Warsz) on January 01, 1979
Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine (2000) 2.25
Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett (2001) 2.15
Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett (1987) 1.62
HLA-B27-associated spondylarthritis in chronic brucellosis. Lancet (1978) 1.51
[Interleukin-6: friend or enemy? Latest findings on the clinical aspects of IL-6]. Orv Hetil (1994) 1.49
Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res (2009) 1.34
Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol (2001) 1.29
Interleukin 6 levels in synovial fluids of patients with different arthritides: correlation with local IgM rheumatoid factor and systemic acute phase protein production. J Rheumatol (1992) 1.25
Histamine: an early messenger in inflammatory and immune reactions. Immunol Today (1992) 1.20
Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin-dependent diabetes mellitus. Pediatr Res (1999) 1.12
Constitutive and IL 1-regulated murine complement gene expression is strain and tissue specific. J Immunol (1987) 1.09
IgE and IgE-rheumatoid factors in circulating immune complexes in rheumatoid arthritis. Ann Rheum Dis (1982) 1.09
Increased interleukin-6 levels, interleukin-6 receptor and gp130 expression in peripheral lymphocytes of patients with inflammatory bowel disease. Scand J Gastroenterol Suppl (1998) 1.09
Radioimmune double PEG precipitation technique for detecting complexed IgE. J Immunol Methods (1979) 1.06
Mouse plasmacytoma: an experimental model of human multiple myeloma. Haematologica (2001) 1.06
Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma. Cell Biol Int (2000) 1.06
CD4(+)CD8(+)TCR(low) thymocytes express low levels of glucocorticoid receptors while being sensitive to glucocorticoid-induced apoptosis. Eur J Immunol (2001) 1.00
Production and flow cytometric application of a monoclonal anti-glucocorticoid receptor antibody. J Immunol Methods (1998) 0.98
Biological and clinical significance of the JAK-STAT pathway; lessons from knockout mice. Inflamm Res (2001) 0.97
IgE class immune complexes in Felty's syndrome: characterisation of antibody activities in isolated complexes. Ann Rheum Dis (1984) 0.97
Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies. Int Arch Allergy Appl Immunol (1981) 0.96
The fifth component of complement (C5) in the mouse. Analysis of the molecular basis for deficiency. J Exp Med (1987) 0.96
Serological abnormalities in juvenile chronic arthritis: a review of 46 cases. Ann Rheum Dis (1980) 0.93
Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases. Rheumatology (Oxford) (2003) 0.93
Meta-analysis of adrenocortical tumour genomics data: novel pathogenic pathways revealed. Oncogene (2010) 0.92
Measurement of intracellular interferon-gamma and interleukin-4 in whole blood T lymphocytes from patients with systemic lupus erythematosus. Immunol Lett (2000) 0.92
N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine increases the permeability of primary mouse cerebral endothelial cell monolayers. Inflamm Res (2003) 0.92
Evaluation of different methods for detecting circulating immune complexes. An inter-laboratory study. J Immunol Methods (1980) 0.92
The role of T-lymphocytes and cytokines in rheumatoid arthritis. Scand J Rheumatol (1996) 0.91
Increased interferon-gamma- and interleukin-4-synthesizing subsets of circulating T lymphocytes in pregnant asthmatics. Clin Exp Allergy (2005) 0.91
Targeted deletion of histidine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss. Proc Natl Acad Sci U S A (2003) 0.90
Asthma from a pharmacogenomic point of view. Br J Pharmacol (2008) 0.89
Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production. Immunol Lett (2000) 0.89
Inhibition of antigen-specific T cell trafficking into the central nervous system via blocking PECAM1/CD31 molecule. J Neuropathol Exp Neurol (2001) 0.88
In vivo pulmonary toxicity of cellulose in rats. J Appl Toxicol (1997) 0.88
DNA polymorphism of MHC III genes in inbred and wild mouse strains. Immunogenetics (1987) 0.87
Human beta 2-microglobulin is a substrate of tissue transglutaminase: polymerization in solution and on the cell surface. J Cell Biol (1981) 0.87
Subsets in psoriatic arthritis formed by cluster analysis. Clin Rheumatol (2001) 0.87
Interrelationship between the immunological and steroid hormone parameters in rheumatoid arthritis. Exp Clin Endocrinol (1986) 0.86
Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy. Pharmacogenomics J (2008) 0.86
Role of cellulose in wood dust-induced fibrosing alveo-bronchiolitis in rat. J Appl Toxicol (1995) 0.86
T lymphocytes are targets for platelet- and trophoblast-derived microvesicles during pregnancy. Placenta (2008) 0.85
Beta2-microglobulin-containing IgG complexes in sera and synovial fluids of rheumatoid arthritis and systemic lupus erythematosus patients. Scand J Immunol (1981) 0.84
Cholinergic signals to and from the immune system. Immunol Lett (1995) 0.83
Histamine influences the expression of the interleukin-6 receptor on human lymphoid, monocytoid and hepatoma cell lines. Agents Actions (1991) 0.83
Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012-1704) of the TSH receptor gene in Graves' disease. Eur J Immunogenet (2000) 0.83
Safety aspects of intravenous immunoglobulins. Immunol Invest (1988) 0.83
Histidine decarboxylase expression in human melanoma. J Invest Dermatol (2000) 0.83
Modulation of glucocorticosteroid binding in human lymphoid, monocytoid and hepatoma cell lines by inflammatory cytokines interleukin (IL)-1 beta, IL-6 and tumour necrosis factor (TNF)-alpha. Scand J Immunol (1993) 0.83
Some aspects of interindividual variations in the metabolism of xenobiotics. Inflamm Res (2003) 0.82
Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation. Immunol Lett (2001) 0.82
Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, is regulated by melanoma-derived histamine. Semin Cancer Biol (2000) 0.82
Cytokine regulation of the acute-phase protein levels in multiple myeloma. Eur J Clin Invest (1998) 0.82
Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes. Cytokine (1998) 0.81
Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis. Med Sci Monit (2001) 0.81
Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotides. J Invest Dermatol (2001) 0.81
H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells. Semin Cancer Biol (2000) 0.81
Natural antibody production in human tonsils. Experientia (1972) 0.81
Evaluation of different methods for detecting circulating immune complexes. Studies in patients with lung cancer. J Immunol Methods (1981) 0.81
Microencapsulation technology by nature: Cell derived extracellular vesicles with therapeutic potential. Eur J Microbiol Immunol (Bp) (2013) 0.81
Autoantibodies specific to beta-2-microglobulin inhibit the Fc receptor-dependent phagocytosis of human monocytes. Immunol Lett (1981) 0.81
Differences between human lymphocyte subpopulations with respect to the uptake and incorporation of [3H]uridine and ribonucleoside triphosphate pools. Biochem Med (1978) 0.80
Effect of histamine on the gene expression and biosynthesis of complement components C2, factor B and C3 in mouse peritoneal macrophages. Immunology (1987) 0.80
The effect of exercise and oxidant-antioxidant intervention on the levels of neurotrophins and free radicals in spinal cord of rats. Spinal Cord (2008) 0.80
Inhibition of human primary melanoma cell proliferation by histamine is enhanced by interleukin-6. Eur J Clin Invest (2002) 0.80
Hepatic regeneration induces transient acute phase reaction: systemic elevation of acute phase reactants and soluble cytokine receptors. Cell Biol Int (2001) 0.80
Complexed rheumatoid factor measurements in sera, synovial fluids and in immune complex fractions. Experientia (1979) 0.80
Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation. Trends Immunol (2001) 0.80
Prevalence of anti-beta-2 microglobulin autoantibodies in sera of rheumatoid arthritis patients with extra-articular manifestations. Ann Rheum Dis (1981) 0.80
Histamine as a potential autocrine regulator of melanoma. Inflamm Res (2001) 0.80
[Association between cumulative familial incidence of type I diabetes and rheumatoid arthritis]. Orv Hetil (1985) 0.80
Interleukin-6-induced production of type II acute phase proteins and expression of junB gene are downregulated by human recombinant growth hormone in vitro. Cell Biol Int (2000) 0.80
Appearance of covalently bound antigen in immune complexes formed during the activation of complement. J Immunol Methods (1984) 0.80
Opposite effect of linearly polarized light on biosynthesis of interleukin-6 in a human B lymphoid cell line and peripheral human monocytes. Cell Biol Int (2002) 0.79